x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Jun 27, 2016 11:34 EST

Acea Biotech, Inc.: Developing Corifungin, a broad spectrum antifungal drug, ready for human trials. Proceeds from this raise will be used for drug mfg and clinical trial cost.

iCrowdNewswire - Jun 27, 2016

Acea Biotech, Inc. Logo

 

 

Acea Biotech, Inc.

 

 

San Francisco, CA 94111, US
Pharmaceuticals
www.aceabiotech.com

Contact Information:

Milton Reeder

View Related News >
support